Pure Biologics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.02	0.01	0.31	3.61	2.26	6.18
Short-Term Investments	-	-	-	-	4.92	26.75
Cash & Short-Term Investments	1.02	0.01	0.31	3.61	7.18	32.93
Cash Growth	350.22%	-96.80%	-91.32%	-49.76%	-78.20%	267.68%
Accounts Receivable	0.51	0.3	0.23	0.02	0.15	0.05
Other Receivables	-	4.42	1.41	14.73	15.07	9.24
Receivables	0.51	4.72	1.63	14.75	15.22	9.29
Prepaid Expenses	-	0	0.02	0.03	0.02	0.03
Other Current Assets	0.05	0.08	0.14	3.22	1.76	0.77
Total Current Assets	1.59	4.81	2.11	21.6	24.17	43.02
Property, Plant & Equipment	-	0.13	0.12	0.88	8.42	3.45
Long-Term Investments	-	-	-	-	0.02	0.02
Other Intangible Assets	-	-	0.12	0.26	0.29	0.33
Long-Term Deferred Charges	-	-	-	-	0.11	0.39
Total Assets	1.59	4.94	2.34	22.74	33.01	47.19
Accounts Payable	-	2.54	0.85	1.03	7.24	0.67
Accrued Expenses	0.12	0.31	0.41	0.92	1.64	0.08
Current Portion of Long-Term Debt	16.45	15.85	13.96	-	-	-
Current Portion of Leases	-	0.03	0.1	0.09	1.1	1.11
Current Unearned Revenue	-	-	-	4.81	2.79	3.68
Other Current Liabilities	1.41	0.23	0.14	1.15	0.08	0
Total Current Liabilities	17.98	18.96	15.46	7.99	12.83	5.55
Long-Term Debt	-	-	-	12.72	-	-
Long-Term Leases	-	0.13	-	0.13	1.77	2
Long-Term Unearned Revenue	-	-	-	-	0.07	0.11
Pension & Post-Retirement Benefits	-	-	-	-	0.04	0.04
Other Long-Term Liabilities	0	-	-	-	-	0
Total Liabilities	17.98	19.09	15.46	20.85	14.71	7.7
Common Stock	1.22	0.82	0.38	0.33	0.23	0.23
Additional Paid-In Capital	106.81	106.81	98.85	90.57	75.31	70.89
Retained Earnings	-124.43	-122.18	-112.36	-92.93	-57.24	-31.63
Comprehensive Income & Other	-	0.41	0.02	3.92	0	-
Shareholders' Equity	-16.39	-14.15	-13.12	1.89	18.3	39.49
Total Liabilities & Equity	1.59	4.94	2.34	22.74	33.01	47.19
Total Debt	16.45	16.01	14.06	12.94	2.86	3.11
Net Cash (Debt)	-15.42	-16	-13.75	-9.33	4.32	29.82
Net Cash Growth	-	-	-	-	-85.52%	654.64%
Net Cash Per Share	-2.13	-3.25	-3.94	-2.93	1.92	13.42
Filing Date Shares Outstanding	12.43	12.24	3.75	3.33	2.25	2.25
Total Common Shares Outstanding	12.43	8.16	3.75	3.33	2.25	2.25
Working Capital	-16.39	-14.14	-13.35	13.61	11.34	37.47
Book Value Per Share	-1.32	-1.73	-3.50	0.57	8.12	17.52
Tangible Book Value	-16.39	-14.15	-13.23	1.64	18.01	39.16
Tangible Book Value Per Share	-1.32	-1.73	-3.53	0.49	7.99	17.37
Land	-	-	-	-	0.1	0.87
Machinery	-	-	-	-	11.95	10.95